Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • U vs GSK✓SelectedUSD · GSKU vs GSK performance historyLatest closeAs of-2.78%11/18
Stock and ETF performance explorer

U vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-74.2%
GSK return
+41.8%
Excess return
-116.0%
Maximum drawdown
-92.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-1.3%-1.4%-2.7%
7D-1.4%-3.1%+1.7%-1.1%
30D+20.7%-0.9%+21.5%+20.7%
3M+4.7%-4.2%+8.9%+5.2%
6M+82.7%-1.6%+84.3%+82.5%
YTD+10.8%+2.6%+8.2%+8.7%
1Y+32.3%+6.2%+26.1%+28.7%
3Y+67.7%+55.0%+12.7%+42.7%
All-74.2%+41.8%-116.0%-78.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling